Associated Papers
Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.
Trieu KG et al.
Cell Reports, 2022
35508126 (PubMed )
Supplement: NIHMS1804986-supplement-2.xlsx › SNV-exonic
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H et al.
Expert Opinion on Drug Metabolism & Toxicology, 2021
Select a paper to view details